(Q46606032)

23 December 2017

title

Changes in liver tests during 1-year treatment of patients with Type 2 diabetes with pioglitazone, metformin or gliclazide (English)

1 reference

23 December 2017

1 reference

1 reference

Belcher G

1

1 reference

23 December 2017

Schernthaner G

series ordinal

2

1 reference

23 December 2017

publication date

1 August 2005

1 reference

23 December 2017

published in

Diabetic Medicine

1 reference

23 December 2017

volume

22

1 reference

23 December 2017

issue

8

1 reference

23 December 2017

page(s)

973-979

1 reference

23 December 2017

Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Nonalcoholic steatohepatitis: Summary of an AASLD Single Topic Conference

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Efficacy and safety of pioglitazone versus metformin in patients with type 2 diabetes mellitus: a double-blind, randomized trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Atherosclerosis in type 2 diabetes mellitus and insulin resistance: mechanistic links and therapeutic targets

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

The fat-derived hormone adiponectin alleviates alcoholic and nonalcoholic fatty liver diseases in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Adiponectin, hepatocellular dysfunction and insulin sensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

Decreased plasma adiponectin concentrations are closely related to hepatic fat content and hepatic insulin resistance in pioglitazone-treated type 2 diabetic patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

A pilot study of a thiazolidinedione, troglitazone, in nonalcoholic steatohepatitis

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1464-5491.2005.01595.X

10.1111/J.1464-5491.2005.01595.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

release_rih3p7hrwzampmfjvpnwkizfgu

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/rih3p7hrwzampmfjvpnwkizfgu

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference

23 December 2017